DSM enters UK distribution partnership with Salutivia

10 Aug 2018 --- Salutivia has been appointed as the UK distributor for DSM Nutritional Products within the food, nutrition and supplement markets for customers served through the DSM distributor supply chain.

Slendacor: Endorsement for study design on weight management solution

07 Aug 2018 --- PLT Health Solutions, Inc. has revealed the results of a clinical study the company helped develop has been published in the highly-regarded scientific journal, Diabetes, Obesity and Metabolism. Entitled “Efficacy of a novel herbal formulation for weight loss demonstrated in a 16‐week randomized, double‐blind, placebo‐controlled clinical trial with healthy overweight adults” (Dixit, et al. 2018), the publication describes clinical evaluation of Slendacor Weight Management Complex, which was introduced to the market in 2017. 

EFSA greenlights novel foods status for Biova’s egg membrane hydrolysate, amid joint health surge

06 Aug 2018 --- 06 Aug 2018 The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has recognized egg membrane hydrolysate BiovaFlex as novel food pursuant to Regulation (EU) 2015/2283. According to the applicant, Biova LLC (the supplier of BiovaFlex), the ingredient holds particular market potential due to its natural sourcing credentials as well as the convenience it brings by being water-soluble.

Essential support: Resource center issues guidance for Indian supplement firms as new regulations come into effect

02 Aug 2018 --- Two new guides have been published in India to help the country’s health supplement industry adapt to recently implemented regulatory requirements. Produced by the Resource Centre for Health Supplements and Nutraceuticals (ReCHaN), their publication is significant because they aim to function as a key stepping stone towards ensuring consistency of practice across India’s supplement industry and will assist in the application of relevant legislation governing the sector.

Lonza ups full year outlook as Capsugel integration starts to boost business

25 Jul 2018 --- Lonza has updated its outlook for the full year after reporting 8.2 percent organic (like-for-like) sales growth, double-digit organic CORE EBITDA and CORE EBIT growth during the first half of 2018. The company attributes growth to the successful integration of Capsugel and “buoyant demand” from pharmaceutical and biotech clients for products including viruses for gene therapy.

US-China trade policies threaten to bite botanicals industry

16 Jul 2018 --- Concerns are being raised that botanicals will be caught in the crossfire of the escalating US-China trade dispute as the Trump Administration’s second list of proposed tariffs targets key ingredients to the food and dietary sector. BI Nutraceuticals President and CEO George Pontiakos, is warning that the latest US government proposal for an additional 10 percent duty on US$200 billion worth of Chinese imports, could adversely affect “a vast range of industries including our own.”

Probiotics: Scientists investigate how seaweed can give a dietary boost to gut bacteria

11 May 2018 --- US researchers examining how to manipulate gut bacteria to boost essential nutrients for better health have been “blown away” by the results they got when using dietary seaweed in mice.

Lonza: Positive start to 2018, driven by expanding healthcare businesses

04 May 2018 --- Lonza has reported a “positive” start to 2018 led by the businesses along the healthcare continuum. The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, has shown a strong performance following good progress on business and functional integration, the company reports, without giving any details on financial figures. For the coming months, Lonza has announced plans to expand facilities in the US.

Nexira enters strategic partnership for nutritionals, not giving up its acquisition plans

02 May 2018 --- Nexira, a global leader in natural and organic ingredients for the food, health and nutrition industries, has announced a strategic partnership agreement with Omega Pharma NV, one of the largest OTC healthcare companies in Europe and Inqpharm Group (a Zaluvida company), a specialty pharmaceutical company.

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 --- Novartis has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical-stage gene therapy company for US$8.7 billion in cash (US$218 per share). The transaction was unanimously approved by the Boards of both companies. The move comes just days after Novartis agreed to sell its stake in a consumer healthcare joint venture for $13 billion to GlaxoSmithKline.

Health claim victory: EFSA confirms physical performance benefits of carbohydrate solutions

14 Mar 2018 --- The European Food Safety Authority (EFSA) has published a scientific assessment confirming the beneficial health effects of glycemic carbohydrates on the improvement of physical performance during high-intensity and long-lasting physical exercise. As a result, sports nutrition companies will be able to include on-pack claims regarding the performance boosting capacity of products containing carbohydrate solutions (CHO). 

Ancient becomes modern: US$103 million investment for bone broth innovator

12 Mar 2018 --- Ancient Nutrition, a bone broth protein and collagen supplement maker, has secured $103 million in funding through strategic minority investment led by VMG Partners. The company, which is the breakthrough pioneer in Bone Broth Protein supplementation that delivers the benefits of “homemade bone broth in a convenient, easy-to-mix form,” revealed a minority investment from VMG Partners, Hillhouse Capital, ICONIQ Capital, and over 100 members of a co-investor network.

Gelita develops controlled soft gelatin capsule fill release

12 Mar 2018 --- Gelita is offering manufacturers of soft gelatin capsules the opportunity to see first hand the complete spectrum of capsule fill release profiles – including the latest addition to Gelita’s pharmaceutical gelatin portfolio: Gelita EC for enteric performance.

US FDA Nutrition Facts label guidance prompts calls for earlier implementation date

02 Mar 2018 --- The commissioner of the US Food and Drug Administration (FDA), Dr. Scott Gottlieb, has issued new guidance on the proposed Nutrition Facts label to help food manufacturers to make the necessary changes by the upcoming compliance dates. In addition, Gottlieb unveiled plans to launch “a major educational campaign for consumers” regarding the revised labels. However, the Center of Science in the Public Interest (CSPI) has noted that with the guidance, an earlier compliance date for all companies for the updated Nutrition Facts label is both “realistic and achievable.”

Non-compliant supplements: Majority of online retailers fall foul of EU regulations

26 Feb 2018 --- A majority of online traders recently surveyed by the European Commission are offering novel foods and food supplements that clearly do not comply with EU regulations. This is according to the results of the first coordinated official controls of Internet marketed foods carried out by 25 EU Member States, Switzerland and Norway. Nearly 1,100 websites were checked for certain products which are non-compliant with EU food legislation. More specifically, the investigation mainly focused on four non-authorized novel foods and food supplements bearing medicinal claims, namely Agmatine (4 aminobutyl) guanidine sulfate, Acacia rigidula, Epimedium grandiflorum and Hoodia gordonii. 

Natures Crops, De Wit Speciality Oils enter into European distribution partnership for Ahiflower oil

15 Feb 2018 --- Natures Crops International and De Wit Speciality Oils have entered into a distribution agreement for Ahiflower oil in the European dietary supplement marketplace. This alliance is thought to add strategic value for both companies through each company’s leading position in manufacturing and marketing nutraceutical products.

Consumer health care: Nestle loses interest in Merck's OTC unit 

05 Feb 2018 --- Nestle has pulled out of the bid for Merck’s consumer health unit, leaving the race to buy the maker of Seven Seas vitamins and various other nutritional supplements without its main contender, Reuters reports. The news came a week after Johnson & Johnson withdrew from the race to buy US drugmaker Pfizer’s consumer health business, leaving Nestlé, GlaxoSmithKline and Reckitt Benckiser among the potential bidders. 

Fermentation focus: Naturex and Cura sign distribution agreement for koji fermented minerals

31 Jan 2018 --- Naturex has signed a global distribution agreement via its Open Innovation program (Ingenium) with Ames-based Cura for their Koji Minerals line of fermented minerals for the dietary supplement and functional food markets. This year’s launches based on Koji fermentation are a stand-alone iron with optimal bioavailability and slow release effect (results supported by two clinical studies) and a blend of seven minerals (iron, zinc, copper, manganese, selenium, molybdenum, chromium) particularly suitable for the multi minerals segment, Naturex reports.

Nestlé and GSK among potential bidders for Pfizer's consumer health unit, after J&J pulls out of race

29 Jan 2018 --- Johnson & Johnson has withdrawn from the race to buy US drugmaker Pfizer’s consumer health business, leaving Nestlé, GlaxoSmithKline and Reckitt Benckiser among the potential bidders, according to Reuters. Pfizer wants to sell the business, which makes Advil painkillers, Centrum multivitamins and Chapstick lip balm, for no less than US$20 billion, sources have told Reuters. The deadline to submit non-binding offers for the unit is on Thursday.

Probi signs agreement with “global FMCG company” on gut health launch, enjoys Asia-Pacific growth

26 Jan 2018 --- Probi is seeking to further expand into the functional food space with a newly signed agreement with an as-of-yet unnamed global FMCG company. The partnership relates to the launch of a product containing Probi’s bacteria for gut health in North America. In its year-end report, Probi [which is majority owned by Symrise] notes that a launch in the North American market is planned for the second half of 2019, potentially followed by launches in other territories. The agreement is expected to have a significant impact on future sales and earnings in Probi’s Functional Food business area. 

loading